A critical discovery in cancer investigation is arising with the use of nanobodies to reactivate dysfunctional p53. This essential cancer suppressor protein is frequently disabled in several types of cancer, leading https://socialdosa.com/story12019853/mini-antibodies-reactivate-the-p53-protein-a-new-hope-for-malignant-therapy